Descargar la presentación
La descarga está en progreso. Por favor, espere
1
New Data and How They Change What We Know About Heart Failure
3
ESC Guidelines for HF: Patient With HFrEF
4
Vicious Cycle of Congestion in Acute HF
5
Recent Acute HF Trials
6
Goals of Treatment in Acute HF
7
Patient With Acute HF
8
Management of Evidence Based Oral Therapies
9
After Initial Stabilization…What’s Next?
10
Initial Management of a Patient With Acute HF
11
HFpEF Trials
12
HFpEF: TOPCAT [a] Results By Region
![HFpEF: TOPCAT [a] Results By Region](http://images.slideplayer.es/71/13626004/slides/slide_12.jpg "HFpEF: TOPCAT [a] Results By Region")
13
ESC Guidelines: HFpEF
14
ACC/AHA/HFSA Guidelines: HFpEF
15
ESC Guidelines: Definition of the Type of HF
16
What We Do Know About HFmrEF?
17
CHARM: Candesartan Reduced CV Death and Time to First HF Hospitalization in HFrEF and HFmrEF Categories
18
Implementation of New Therapies in HF
19
PARADIGM-HF Primary Results: Significant Reduction in Primary Endpoints, CV Death, and All-Cause Mortality
20
How Do We Better Optimize Treatment?
21
Conclusions
22
Abbreviations
23
Abbreviations (cont)
Presentaciones similares
